[Advances in the treatment of breast carcinoma. New therapy schedules with astonishing success quotas].
Aumiller
Jochen
J
D000367:Age Factors; D000077384:Anastrozole; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008327:Mammography; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D009570:Nitriles / Q000008:administration & dosage / Q000627:therapeutic use; D017698:Postmenopause; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use; D043823:Taxoids / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D000068878:Trastuzumab; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D047072:Aromatase Inhibitors; D009570:Nitriles; D043823:Taxoids; D014230:Triazoles; D013629:Tamoxifen; D000077143:Docetaxel; D000077384:Anastrozole; D000068878:Trastuzumab